StockData

agilon health vs PACS

AGL and PACS side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AGL and PACS compare

PACS is the larger company, worth 4.0 times as much as agilon health ($7.7B against $1.9B).

PACS grew revenue faster over the last twelve months (15.2% versus 0.32% for agilon health).

PACS keeps more of each dollar of sales as profit, with a net margin of 4.8% compared with −3.9% at agilon health.

PACS scores higher on the StockData Score (12 against 4 for agilon health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAGLPACS
Size and price
Market cap$1.9B$7.7B
Share price$115.20$48.55
Change, 1 year700%359%
Change, 5 years−78.7%–
Beta (5Y)5.410.65
Employees85647K
StockData Score
Total score412 (better)
Valuation score11
Growth score14 (better)
Performance score14 (better)
Health score13 (better)
Dividend score00
Valuation
P/E–27.7×
P/S0.3× (better)1.4×
P/B–6.9×
EV/EBITDA–18.9×
PEG–19.75
FCF yield−4.4%–
Fair value–$39.49
Margin of safety–−22.9%
Growth
Revenue growth (TTM)0.32%15.2% (better)
Revenue growth, 5Y average37.2%–
Net income growth (TTM)–104%
EPS growth (TTM)–113%
Profitability
Gross margin–23.5%
Operating margin−5.2%7.4% (better)
Net margin−3.9%4.8% (better)
FCF margin−1.4%–
Return on equity–28.1%
Return on invested capital–29.4%
Financial health
Debt / equity–0.22
Net debt / EBITDA–0.20
Interest coverage−44.4×13.9× (better)
Current ratio1.08 (better)0.91
Altman Z-score2.332.33 (better)
Piotroski F-score27 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions95.8%31.3%
Held by insiders10.1%78.5%
Insider net buying, 12 months$300K (better)−$119M
Superinvestors holding1–
Short interest, % of float5.6%12.6%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.